New-onset graves’ disease after the initiation of nivolumab therapy for gastric cancer: a case report
2020 · BMC Endocrine Disorders · 17 citations
https://doi.org/10.1186/s12902-020-00613-5
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
Hiroshi Yamada is an academic researcher.
ORCID: 0000-0003-1674-3784Click to start Chat